NewsBur
No Result
View All Result
Wednesday, January 27, 2021
  • Home
  • Morning News
  • Market News
  • Analyst Actions
  • Trending Stocks
Subscribe
Newsbur
  • Home
  • Morning News
  • Market News
  • Analyst Actions
  • Trending Stocks
No Result
View All Result
Newsbur
No Result
View All Result
Home Trending Stocks

Ironwood Pharmaceuticals Inc. [IRWD] is One of the Best Plays in Healthcare and This Proves It

by Timothy Webb
October 9, 2020
in Trending Stocks
0
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Ironwood Pharmaceuticals Inc. [NASDAQ:IRWD] is flashing a current price of $10.49. On Thursday, the company’s daily low is at $9.77 as the high is reaching $10.505.

The price per sales of 3.92 and price per cash flow of 14.14. The company is also booking 0.62 earnings per share.

IRWD’s next earning date is 10/29/2020. The company has price per sales of 3.92 and price per cash flow of 14.14. The company is also booking 0.62 earnings per share.

The Price is right

Holding a Market Cap of $1.67 billion, Ironwood Pharmaceuticals Inc. has seen a trading range over the last year of $7.99-$14.10.

For the last five days, IRWD is up from its last closing price. The average shares trading hands each day is 1.96M.

Using a Force Index Indicator is a good way to look at how strong actual buying and selling pressure is for IRWD. When we apply the Elder Force Index to Ironwood Pharmaceuticals Inc., we are seeing an Elder Force Indicator number of 1535456.79.

Recent Performance

The recent performance of the stock is another area that can tell traders how to proceed. IRWD is presenting an interesting case. This can be seen in the Forward P/E ratio, which currently stands at 9.55.

In the last quarter, IRWD made a profit of 89.43 million. Ironwood Pharmaceuticals Inc. also saw quarter revenue growth year over year of 23.59%.

Technical Analysis

Looking at popular technical indicators, the company’s 5-day moving average is 9.70 compared to the 50-day moving average of 13.00%. So, traders might want to tread carefully if they are going to bid.

The Relative Strength Index or RSI is an indicator ranging between 0 and 100 that traders use to determine if a stock is “overbought” or “oversold.” A strong uptrend tending to reach into the “overbought” status is above 70, while a downward trend will stay around the 30 mark. IRWD currently holds a 9-day RSI of 73.42%, while 100-day RSI stands at 50.18%.

Another indicator we believe is worth keeping tabs on is the Moving Average Convergence Divergence or MACD. Similar to the concept of the Force Index — on the basis of price momentum — the MACD gives traders a tool to measure the turning point of a stock even during rapid fluctuations in price. Buy and sell signals are determined by a stock’s relation to the zero line, so if a stock is above a zero line for many weeks it might be a “buy.” On the other hand, if a stock is below the zero line consistently, it might be one to stay away from. Also, if the MACD line reaches a peak and dips, its momentum may be waning. IRWD’s 9-day MACD is 0.42 and the company’s 100-day MACD stands at -0.06.

Inside Moves

Another area that is important to analyze is insider moves and majority shareholders. While this is not always an error-free way to tell what the future holds for a stock, you can maybe gather important information from reading the tea leaves about who is buying and selling.

The major holders for this stock are 3.20% by insiders and 114.72% by institutions. Regarding institutional holdings, Wellington Management Company, LLP owns 13.89%, while the second top holder, Brown Capital Management, Inc., currently owns 11.75%.

Over the last six months, insiders have sold 7,950 with the most recent transaction from McHugh Julie, Director, with a sell at price 9.77 per share.

Conclusion

Overall, the recommended rating for IRWD is Moderate Buy. Currently, the company has 5 analysts watching the stock, and the average quarterly earnings estimate is 0.15. Quarterly revenue estimates are averaging 97.56M with the high estimate reaching 101.5M and the low at 95.61M.

To review, the current 1-year target estimate is sitting at 10.50, while the current price 10.49. Based on this, we expect the stock to rise considering the aforementioned fundamentals.

Tags: Ironwood Pharmaceuticals Inc.IRWDIRWD stockNASDAQ:IRWD

Recommended Stories

Here’s Why Diversified Healthcare Trust [DHC] Stock Traded 0.15 Higher

September 11, 2020

After-Hours Trading Alert: The Kroger Co. [KR] is Up 0.78% After the Bell

September 15, 2020

Amneal Pharmaceuticals Inc. [AMRX] Raise 6.49%

October 8, 2020

Popular Stories

  • Sorrento Therapeutics Inc. [SRNE] is One of the Best Plays in Healthcare and This Proves It

    0 shares
    Share 0 Tweet 0
  • Heat Biologics Inc. [HTBX] is One of the Best Plays in Healthcare and This Proves It

    0 shares
    Share 0 Tweet 0
  • Heat Biologics Inc. [HTBX] Is Skyrocketing 13.15% on Pure Fundamentals

    0 shares
    Share 0 Tweet 0
  • BlackBerry Limited [BB] is a Top Ten Buy with Quarterly Revenues of 999.00M

    0 shares
    Share 0 Tweet 0
  • Impressive Profit Margins of -5.80% Raise Bull Flags for General Electric Company [GE]

    0 shares
    Share 0 Tweet 0

NewsBur.com

Newsbur.com is an Economic news website, which offers broad information about the Stock markets and Equities. The major emphasis of this platform is to present, the most practical recommendation for public and private capital sharing, both in the form of updates and detailed analysis.

Recent Posts

  • After-Hours Trading Alert: Amgen Inc. [AMGN] is Up 0.85% After the Bell
  • Has Dynatrace Inc. [DT] Completely Outpaced Other Companies in the Technology This Year?
  • Why Applied Materials Inc. [AMAT]’s 1.55% Drop is No Cause for Alarm

Categories

  • Analyst Actions
  • Market News
  • Morning News
  • Trending Stocks
  • Uncategorized

© 2020 Copyright © All Rights Reserved.

No Result
View All Result
  • Home
  • Market News
  • Morning News
  • Analyst Actions
  • Trending Stocks

© 2020 Copyright © All Rights Reserved.